Study on Epcoritamab for Patients with Relapsed or Refractory Large B Cell Lymphoma
- Substances:EpcoritamabLenalidomide+1
Spain- Participants:18–64 years · 65+ years
- Substances:Epcoritamab
- Sponsor:Fundacion Geltamo
Rare diseases
Investigational molecules
Locations
Back to Spain151 clinical trials in Caceres, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainStudy on the Safety and Effectiveness of Cytisinicline for Helping Smokers Quit
SpainStudy on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
SpainStudy on the Safety of Eganelisib Alone and with Cytarabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes
SpainStudy on Encorafenib, Binimetinib, Cemiplimab, and Fianlimab for Patients with BRAF-Mutated Melanoma and Brain Metastases
SpainStudy on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer
SpainStudy on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors
SpainStudy of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors
SpainStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
SpainStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
SpainStudy on Alisertib with Hormone Therapy for Patients with HR+, HER2- Recurrent or Metastatic Breast Cancer
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myeloid leukemia and related blood disorders, evaluating novel therapeutic combinations and treatment approaches.
Studies include investigations of eganelisib, RVU120, and other promising compounds for refractory conditions.
Innovative trials examining treatments for coronary artery disease and related cardiovascular conditions, including specialized therapies for arterial dissection.
Research includes evaluation of novel medications and therapeutic approaches for various cardiac conditions.
Comprehensive research in breast cancer and melanoma, investigating targeted therapies and combination treatments for various cancer types.
Multiple trials exploring innovative treatment approaches for both early-stage and advanced cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.